04/11/2024
7:00 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
3:26 PM | Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:24 PM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:14 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:39 PM | Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
11:04 AM | Collegium Pharmaceutical (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
|
01/19/2024
1:40 PM | BlackRock Inc. (Filed by)
Collegium Pharmaceutical (Subject)
| Form SC 13G/A | |
01/18/2024
3:19 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
3:36 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:51 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:28 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
3:32 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
4:00 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:40 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
9:19 AM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2023
6:08 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
9:04 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
3:10 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
3:15 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
8:58 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023
11:10 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023
3:37 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:38 PM | Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:38 PM | Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:39 PM | Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:39 PM | Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:40 PM | Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:40 PM | Collegium Pharmaceutical (Issuer)
McFarlane Neil F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:40 PM | Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
